flubendazole has been researched along with Alveolar Echinococcosis, Hepatic in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (83.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bardonnet, K; Blagosklonov, O; Bresson-Hadni, S; Delabrousse, E; Grenouillet, F; Mantion, GA; Miguet, JP; Vuitton, DA | 1 |
Barale, T; Capron, A; Hervé, P; Lasségue, A; Miguet, JP; Seillés, E; Vuitton, DA | 1 |
Barale, T; Estavoyer, JM; Gillet, M; Lassègue, A; Miguet, JP; Minazzi, H; Vuitton, D | 1 |
Canton, P; Dureux, JB; Gérard, A; Roche, G | 1 |
Coulaud, JP; Hay, JM; Manuel, C; Meulemans, A; Mohler, J; Saimot, AG | 1 |
Bracard, S; Claudon, P; Floquet, J; Gérard, A; Jacquier, P; Vespignani, H; Weber, M | 1 |
1 review(s) available for flubendazole and Alveolar Echinococcosis, Hepatic
Article | Year |
---|---|
[Neurological manifestations of alveolar echinococcosis].
Topics: Aged; Brain Diseases; Echinococcosis, Hepatic; Echinococcosis, Pulmonary; Electroencephalography; Female; Humans; Male; Mebendazole; Middle Aged; Recurrence; Spinal Cord Compression | 1988 |
1 trial(s) available for flubendazole and Alveolar Echinococcosis, Hepatic
Article | Year |
---|---|
Humoral and cellular immunity in patients with hepatic alveolar echinococcosis. A 2 year follow-up with and without flubendazole treatment.
Topics: Adult; Aged; Antibodies; Antibody Formation; Antinematodal Agents; Benzimidazoles; Clinical Trials as Topic; Complement C4; Complement System Proteins; Echinococcosis, Hepatic; Female; Follow-Up Studies; Hemagglutination Tests; Humans; Immunity, Cellular; Immunoelectrophoresis; Immunoglobulin A; Immunoglobulin G; Male; Mebendazole; Middle Aged | 1984 |
4 other study(ies) available for flubendazole and Alveolar Echinococcosis, Hepatic
Article | Year |
---|---|
30-yr course and favorable outcome of alveolar echinococcosis despite multiple metastatic organ involvement in a non-immune suppressed patient.
Topics: Adult; Albendazole; Antinematodal Agents; Echinococcosis; Echinococcosis, Hepatic; Follow-Up Studies; Humans; Immunosuppression Therapy; Liver Diseases; Lung; Lung Diseases; Male; Mebendazole; Positron-Emission Tomography; Treatment Outcome | 2013 |
[Treatment of human alveolar echinococcosis with flubendazole. Clinical, morphological and immunological study].
Topics: Adult; Antibodies; Benzimidazoles; Echinococcosis, Hepatic; Female; Humans; Male; Mebendazole; Middle Aged | 1984 |
[Treatment of alveolar echinococcosis with flubendazole. Pharmacological study (author's transl)].
Topics: Anticestodal Agents; Benzimidazoles; Echinococcosis, Hepatic; Humans; Kinetics; Liver; Mebendazole; Radioimmunoassay | 1982 |
[Pharmacokinetic study of flubendazole in human hydatid disease caused by Echinococcus granulosus. Preliminary results (author's transl)].
Topics: Adult; Anticestodal Agents; Benzimidazoles; Echinococcosis; Echinococcosis, Hepatic; Female; Humans; Kinetics; Male; Mebendazole; Radioimmunoassay; Splenic Diseases | 1981 |